Preparing for a post-placebo paradigm: Ethics and choice of control in clinical trials

American Journal of Bioethics

Volumn 9, Issue 9, 2009, Pages 51-52

  Nunn, Robin ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ARTICLE; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; EMOTION; ETHICS; HUMAN; METHODOLOGY; PERSONNEL; PLACEBO EFFECT; PSYCHOLOGICAL ASPECT; RESEARCH ETHICS; RESEARCH SUBJECT; THINKING;

CONTROLLED CLINICAL TRIALS AS TOPIC; DOUBLE-BLIND METHOD; EMOTIONS; ETHICS, RESEARCH; HUMANS; PLACEBO EFFECT; PLACEBOS; RESEARCH DESIGN; RESEARCH PERSONNEL; RESEARCH SUBJECTS; THINKING;

EID: 70449563007     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265160903093854     Document Type: Article

References (6)

1. Colloca, L. and Benedetti, F. 2005. Placebos and painkillers: Is mind as real as matter? Nature Reviews Neuroscience 6: 545-552.
2. Dworkin, R. W. 2009. A clinical perspective on placebo research: Looking back, looking forward. American Journal of Bioethics-Neuroscience 9(9): 54-55.
3. Harrington, A. 2006. The many meanings of the placebo effect: Where they came from, why they matter. BioSocieties 1: 181-193.
4. Howick, J. 2009. Questioning the methodologic superiority of 'placebo'over 'active'controlled trials. American Journal of Bioethics-Neuroscience 9(9): 34-48.
5. Nunn, R. 2009. It's time to put the placebo out of our misery. British Medical Journal 338: b1568.
6. Scottish Society of Physicians. 1971. Ischaemic heart disease: A sec- ondary prevention trial using clofibrate. Report by a research com- mittee of the Scottish Society of Physicians. British Medical Journal 4: 775-784.